e8vk
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 4, 2011 (December 29, 2010)
CALUMET SPECIALTY PRODUCTS PARTNERS, L.P.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
000-51734
|
|
37-1516132 |
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer |
of incorporation)
|
|
|
|
Identification No.) |
2780 Waterfront Pkwy E. Drive
Suite 200
Indianapolis, Indiana 46214
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code (317) 328-5660
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
Effective December 31, 2010, Allan A. Moyes, III (Mr. Moyes) retired from his position as
Executive Vice President of Calumet GP, LLC (the General Partner), the general partner of Calumet
Specialty Products Partners, L.P. (the Company).
In connection with his retirement, the General Partner and Mr. Moyes entered into a
Reaffirmation Agreement, General Release and Covenant Not to Sue, dated effective as of December
29, 2010 (the Reaffirmation Agreement), a form of which was originally attached as Exhibit A to
the Professional Services and Transition Agreement, dated November 2, 2009, entered into by and
between the General Partner and Mr. Moyes (Exhibit 10.1 to the Current Report on Form 8-K filed
with the Securities & Exchange Commission on November 6, 2009 (File No 000-51734)). Under the
Reaffirmation Agreement, the final day of Mr. Moyes employment by the General Partner was December 31,
2010 and, beginning January 1, 2011, Mr. Moyes will be reimbursed for the applicable premiums to
continue health care benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985
(COBRA) for a period of 32 weeks, together with an additional cash payment in an amount necessary
to put Mr. Moyes in the same after-tax position he would be in had he been covered under the
Companys health care plan as an employee. In addition, under the Reaffirmation Agreement, the
Company has agreed to convey to Mr. Moyes title to the company vehicle that he used during his
employment. Under the Reaffirmation Agreement, Mr. Moyes has agreed to waive and release any and
all claims he may have against the General Partner, the Company or any of their respective
affiliates related to his employment, cessation of his employment or the compensation or benefits
payable in connection with such employment or cessation of employment. The foregoing description
of the Reaffirmation Agreement is qualified in its entirety by reference to the Reaffirmation
Agreement, a copy of which is attached hereto as Exhibit 10.26 to this Current Report on Form 8-K
and incorporated herein by reference.
Any unvested phantom units held by Mr. Moyes under the Calumet Specialty Products Partners,
L.P. Executive Deferred Compensation Plan immediately vested upon Mr. Moyes retirement.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit Number |
|
Description |
Exhibit 10.26
|
|
Reaffirmation Agreement, General Release and Covenant
Not to Sue, dated December 22, 2010 and
effective as of December 29, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
CALUMET SPECIALTY PRODUCTS
PARTNERS, L.P.
|
|
|
By: |
CALUMET GP, LLC,
|
|
|
|
its General Partner |
|
|
|
|
|
By: |
/s/ R. Patrick Murray, II
|
|
|
|
Name: |
R. Patrick Murray, II |
|
|
|
Title: |
Vice President, Chief Financial Officer and
Secretary |
|
|
January 4, 2011
EXHIBIT INDEX
|
|
|
Exhibit Number |
|
Description |
Exhibit 10.26
|
|
Reaffirmation Agreement, General Release and Covenant
Not to Sue, dated December 22, 2010 and
effective as of December 29, 2010. |